Abacus Medicine Group announces new Chief Financial Officer

Peter Rønnest Andersen joins the chief executive management team on April 1st

15 FEBRUARY 2021

The Abacus Medicine Group has successfully concluded its search for a new Chief Financial Officer (CFO). From 1st April 2021, Peter Rønnest Andersen will officially take over the responsibility as CFO.

Peter Rønnest Andersen (53) has extensive experience in the role as CFO in global companies. His professional background includes almost 20 years in Maersk and for the last 7 years the position as Group CFO at Haldor Topsøe.

“I am proud and delighted to welcome Peter Rønnest Andersen to Abacus Medicine,” says CEO Flemming Wagner. “Our business is growing fast in both size and complexity, and Peter has the right competence and capacity to help us stay on course towards even further growth.”

“Welcoming Peter also means saying goodbye to our current CFO Henrik Knudsen, who has informed me that he wishes to seek new opportunities. Henrik Knudsen joined Abacus Medicine in 2013, and his dedicated contribution has been invaluable. Today, the revenue of Abacus Medicine is 10 times higher than it was then. I wish him the best of luck in the future,” says CEO Flemming Wagner.